Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT01515137 · COMPLETED

Trial details

NCT number: NCT01515137
Sponsor: University of Pittsburgh
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2005-11-01
Primary completion: 2014-09-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.